GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SpectraCure AB (OSTO:SPEC) » Definitions » Gross Profit

SpectraCure AB (OSTO:SPEC) Gross Profit : kr9.77 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SpectraCure AB Gross Profit?

SpectraCure AB's gross profit for the three months ended in Dec. 2024 was kr2.36 Mil. SpectraCure AB's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was kr9.77 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. SpectraCure AB's gross profit for the three months ended in Dec. 2024 was kr2.36 Mil. SpectraCure AB's Revenue for the three months ended in Dec. 2024 was kr0.00 Mil. Therefore, SpectraCure AB's Gross Margin % for the quarter that ended in Dec. 2024 was %.

SpectraCure AB had a gross margin of % for the quarter that ended in Dec. 2024 => No sustainable competitive advantage

During the past 11 years, the highest Gross Margin % of SpectraCure AB was 757.80%. The lowest was 131.96%. And the median was 699.61%.


SpectraCure AB Gross Profit Historical Data

The historical data trend for SpectraCure AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SpectraCure AB Gross Profit Chart

SpectraCure AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.35 1.39 3.05 9.54 9.77

SpectraCure AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 2.68 2.28 2.45 2.36

Competitive Comparison of SpectraCure AB's Gross Profit

For the Medical Devices subindustry, SpectraCure AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SpectraCure AB's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SpectraCure AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where SpectraCure AB's Gross Profit falls into.


;
;

SpectraCure AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

SpectraCure AB's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=0 - -9.766
=9.77

SpectraCure AB's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=0 - -2.359
=2.36

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9.77 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

SpectraCure AB's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=2.36 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


SpectraCure AB  (OSTO:SPEC) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

SpectraCure AB had a gross margin of % for the quarter that ended in Dec. 2024 => No sustainable competitive advantage


SpectraCure AB Gross Profit Related Terms

Thank you for viewing the detailed overview of SpectraCure AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


SpectraCure AB Business Description

Traded in Other Exchanges
Address
Magistratsvagen 10, Lund, SWE, 22643
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.